One secretive company’s new technology is poised to disrupt the AI market – a market that is projected to grow from roughly $500 billion to $200 trillion.
That’s a surge of 39,900% over the next six years.
Today, you can invest in this one-of-a-kind company for just $25 a share.
By 2030, Wall Street experts predict it could generate more revenue than the top 10 best-selling drugs… combined. Early investors stand to reap tremendous rewards as it’s growth surges 75,000% by 2030.
It’s being called “a miracle.”
And the “holy grail of medicine.”
That’s “widely expected to be one of the top selling medicines in history.”
Which is why some Wall Street analysts are predicting weight loss drugs will generate $200 billion annually by 2030.
That’s more revenue than the top 10 best-selling medicines generate right now…
Combined.
But former hedge fund manager Ian King says Wall Street is WRONG.
Because of one line he found in this official FDA document, he says Wall Street is vastly UNDERESTIMATING the potential.
Instead…
Ian predicts this could become the world’s first trillion-dollar drug. And he’s recommending 3 little-known stocks to play this fast-moving trend.
30 Energy companies have been legally approved to payout $17.9 billion dollars to investors in the form of “MLP Checks” this year. Click here for details.
See you soon!
(c) 2024 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096) Legal Notice
The mailbox associated with this email address is not monitored, so please do not reply.
Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: http://banyanhill.com/contact-us
Tidak ada komentar:
Posting Komentar